JP2025011201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025011201A5 JP2025011201A5 JP2024177043A JP2024177043A JP2025011201A5 JP 2025011201 A5 JP2025011201 A5 JP 2025011201A5 JP 2024177043 A JP2024177043 A JP 2024177043A JP 2024177043 A JP2024177043 A JP 2024177043A JP 2025011201 A5 JP2025011201 A5 JP 2025011201A5
- Authority
- JP
- Japan
- Prior art keywords
- substitution
- receptor
- antigen
- killer cell
- hiv antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871393P | 2019-07-08 | 2019-07-08 | |
| US62/871,393 | 2019-07-08 | ||
| JP2022500950A JP7700093B2 (ja) | 2019-07-08 | 2020-07-08 | 多反応性が低下した抗ｈｉｖワクチン抗体 |
| PCT/US2020/041138 WO2021007285A1 (en) | 2019-07-08 | 2020-07-08 | Anti-hiv vaccine antibodies with reduced polyreactivity |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500950A Division JP7700093B2 (ja) | 2019-07-08 | 2020-07-08 | 多反応性が低下した抗ｈｉｖワクチン抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025011201A JP2025011201A (ja) | 2025-01-23 |
| JP2025011201A5 true JP2025011201A5 (cg-RX-API-DMAC10.html) | 2026-01-09 |
Family
ID=74114255
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500950A Active JP7700093B2 (ja) | 2019-07-08 | 2020-07-08 | 多反応性が低下した抗ｈｉｖワクチン抗体 |
| JP2024177043A Pending JP2025011201A (ja) | 2019-07-08 | 2024-10-09 | 多反応性が低下した抗ｈｉｖワクチン抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500950A Active JP7700093B2 (ja) | 2019-07-08 | 2020-07-08 | 多反応性が低下した抗ｈｉｖワクチン抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12459990B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3997119A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7700093B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20220047977A (cg-RX-API-DMAC10.html) |
| CN (1) | CN114641488B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020311902A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3146372A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202116800A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021007285A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240279331A1 (en) * | 2021-06-11 | 2024-08-22 | The Regents Of The University Of California | Antibodies that stimulate nk cell-mediated cytotoxicity |
| WO2024097957A1 (en) * | 2022-11-03 | 2024-05-10 | Duke University | Novel antibodies for hiv and methods of making and using the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013090644A2 (en) | 2011-12-13 | 2013-06-20 | California Institute Of Technology | Anti-hiv antibodies having increased potency and breadth |
| WO2014205491A1 (en) * | 2013-06-25 | 2014-12-31 | Monash University | Biological molecules and methods of use |
| US20180028658A1 (en) | 2015-02-16 | 2018-02-01 | New York Blood Center, Inc. | Antibody-drug conjugates for reducing the latent hiv reservoir |
| WO2016149695A1 (en) | 2015-03-19 | 2016-09-22 | Duke University | HIV-1 NEUTRALIZING ANTIBODIES AND USES THEREOF (CD4bs ANTIBODIES) |
| AU2016249404B2 (en) * | 2015-04-17 | 2021-01-21 | Igm Biosciences, Inc. | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof |
| JP6732915B2 (ja) | 2015-12-15 | 2020-07-29 | ギリアード サイエンシーズ， インコーポレイテッド | ヒト免疫不全ウイルス中和抗体 |
| EP3601334A4 (en) * | 2017-03-27 | 2021-03-31 | The Wistar Institute Of Anatomy And Biology | Dna antibody constructs for use against hiv |
| IL317993B2 (en) * | 2018-07-03 | 2025-11-01 | Gilead Sciences Inc | Antibodies directed against HIV gp120 and methods of use |
-
2020
- 2020-07-08 WO PCT/US2020/041138 patent/WO2021007285A1/en not_active Ceased
- 2020-07-08 EP EP20836440.6A patent/EP3997119A4/en active Pending
- 2020-07-08 AU AU2020311902A patent/AU2020311902A1/en active Pending
- 2020-07-08 KR KR1020227004133A patent/KR20220047977A/ko active Pending
- 2020-07-08 CA CA3146372A patent/CA3146372A1/en active Pending
- 2020-07-08 CN CN202080074694.7A patent/CN114641488B/zh active Active
- 2020-07-08 JP JP2022500950A patent/JP7700093B2/ja active Active
- 2020-07-08 US US17/625,247 patent/US12459990B2/en active Active
- 2020-07-08 TW TW109123108A patent/TW202116800A/zh unknown
-
2024
- 2024-10-09 JP JP2024177043A patent/JP2025011201A/ja active Pending
-
2025
- 2025-09-29 US US19/343,891 patent/US20260022162A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11597759B2 (en) | Multispecific antibodies that target HIV GP120 and CD3 | |
| CN108610420B (zh) | 抗cd19的人源化抗体以及靶向cd19的免疫效应细胞 | |
| TWI593706B (zh) | 抗αβＴＣＲ抗體 | |
| CN105669863B (zh) | 一种能与人内皮素受体特异性结合的抗体及其应用 | |
| US10344077B2 (en) | HIV-1 neutralizing antibodies and uses thereof (V3 antibodies) | |
| IL258822B2 (en) | Trispecific and/or terrivalent binding proteins for the prevention or treatment of HIV infection | |
| CA3102859A1 (en) | Antibodies that target hiv gp120 and methods of use | |
| JP2018533371A5 (cg-RX-API-DMAC10.html) | ||
| US12247072B2 (en) | IL-21 polypeptides and targeted constructs | |
| JPWO1994020632A1 (ja) | 抗ｈｉｖモノクローナル抗体 | |
| JP2024540054A (ja) | 癌を治療する方法及びｂｃｍａ×ｃｄ３二重特異性抗体の有効性を向上させる方法 | |
| TW200846363A (en) | Novel human anti-R7V antibodies and uses thereof | |
| CN111670203A (zh) | 双特异性抗体 | |
| JP2025537692A (ja) | 癌を治療する方法 | |
| CN117083299A (zh) | Cldn18.2抗原结合蛋白及其用途 | |
| US20210246194A1 (en) | Optimized gp41-Binding Molecules and Uses Thereof | |
| US20250339519A1 (en) | Combination of cytokine fusion proteins with cd8 antigen binding molecules | |
| HK40129535A (en) | Il-21 polypeptides and targeted constructs | |
| JP2024540053A (ja) | 癌を治療する方法及びｇｐｒｃ５ｄｘｃｄ３二重特異性抗体の有効性を向上させる方法 | |
| HK40017754A (en) | Multispecific antibodies that target hiv gp120 and cd3 | |
| HK40017754B (en) | Multispecific antibodies that target hiv gp120 and cd3 |